Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder

被引:66
作者
Talarowska, Monika [1 ]
Galecki, Piotr [1 ]
Maes, Michael [2 ]
Orzechowska, Agata [1 ]
Chamielec, Marcelina [1 ]
Bartosz, Grzegorz [3 ,4 ]
Kowalczyk, Edward [5 ]
机构
[1] Med Univ Lodz, Dept Adult Psychiat, PL-91229 Lodz, Poland
[2] Piyavate Hosp, Maes Clin TRIA, Bangkok 10310, Thailand
[3] Med Univ Lodz, Dept Mol Biophys, PL-91229 Lodz, Poland
[4] Univ Rzeszow, Dept Biochem & Cell Biol, Rzeszow, Poland
[5] Med Univ Lodz, Dept Pharmacol & Toxicol, PL-91229 Lodz, Poland
关键词
Depression; Nitric oxide; Cognitive impairment; OXIDATIVE STRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SPATIAL MEMORY; HOMOCYSTEINE; DEMENTIA; DECLINE; INTERFERENCE; METABOLITES; EXPRESSION;
D O I
10.1016/j.neulet.2012.01.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background/aim: Depressive disorders are multifactorial diseases, in which cognitive impairment is one of the characteristic feature. One of the molecules that regulate of various cognitive, emotional and behavioural processes is nitric oxide (NO), synthesized from L-arginine by a family of isoformic enzymes known as nitric oxide synthases (NOS). NO is a gaseous compounds that acts as a biological second messenger in a number of organ system. In addition, NO is a ubiquitous free radical ((NO)-N-center dot) that affects many normal physiologic functions but is also implicated in the etiology and progression of many diseases. The aim of the study was to determine the concentration of NO in patients with recurrent depressive disorder (rDD) and to define relationship between plasma NO levels and the cognitive performance. Methods: The study comprised 78 subjects: patients with rDD (n = 45), healthy controls (CG, n = 33). Cognitive function assessment was based on: TMT, The Stroop Test, VFT, AVLT. Results: Statistically significant differences were found among patients with rDD in the intensity of depression symptoms, measured by the HORS on therapy onset vs. the examination results after 8 weeks of treatment (p < 0.001). The level of NO was substantially higher in patients with rDD compared to CG. For all examined subjects (p < 0.001), elevated levels of NO in blood plasma adversely affect the efficiency of visual-spatial and auditory-verbal working memory as well as short-term declarative memory. For rDD patients, elevated NO levels were associated with worse cognitive test performance. The higher was the concentration of plasma NO, the greater was the severity of depressive symptoms measured by HDRS (p = 0.03). Conclusions: (1) Higher concentration of plasma NO in rDD patients is associated with the severity of depressive symptoms. (2) Elevated levels of plasma NO are related to impairment of visual-spatial and auditory-verbal working memory as well as to impairment of short-term declarative memory. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 47 条
  • [1] iNOS-mediated nitric oxide production and its regulation
    Aktan, F
    [J]. LIFE SCIENCES, 2004, 75 (06) : 639 - 653
  • [2] [Anonymous], 2012, The WHO application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: IDC-MM
  • [3] Modifications of platelet from Alzheimer disease patients: A possible relation between membrane properties and NO metabolites
    Arianna, Vignini
    Laura, Nanetti
    Cinzia, Moroni
    Laura, Tanase
    Marco, Bartolini
    Simona, Luzzi
    Leandro, Provinciali
    Laura, Mazzanti
    [J]. NEUROBIOLOGY OF AGING, 2007, 28 (07) : 987 - 994
  • [4] The classical Stroop interference task as a prefrontal activation probe:: a validation study using 99Tcm-ECD brain SPECT
    Audenaert, K
    Lahorte, P
    Brans, B
    Van Laere, K
    Goethals, I
    Van Heeringen, K
    Dierckx, RA
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (02) : 135 - 143
  • [5] Endothelial Nitric Oxide Modulates Expression and Processing of Amyloid Precursor Protein
    Austin, Susan A.
    Santhanam, Anantha V.
    Katusic, Zvonimir S.
    [J]. CIRCULATION RESEARCH, 2010, 107 (12) : 1498 - +
  • [6] Markers of inflammation and their clinical significance
    Ballantyne, C
    Nambi, V
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (02) : 21 - 29
  • [7] PLASMA HOMOCYSTEINE IN VASCULAR-DISEASE AND IN NONVASCULAR DEMENTIA OF DEPRESSED ELDERLY PEOPLE
    BELL, IR
    EDMAN, JS
    SELHUB, J
    MORROW, FD
    MARBY, DW
    KAYNE, HL
    COLE, JO
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1992, 86 (05) : 386 - 390
  • [8] Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion
    Cai Z.-Y.
    Yan Y.
    Sun S.-Q.
    Zhang J.
    Huang L.-G.
    Yan N.
    Wu F.
    Li J.-Y.
    [J]. Neuroscience Bulletin, 2008, 24 (5) : 305 - 313
  • [9] Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients
    Chrapko, Wendy
    Jurasz, Paul
    Radomski, Marek W.
    Archer, Stephen L.
    Newman, Stephen C.
    Baker, Glen
    Lara, Nathalie
    Le Mellédo, Jean-Michel
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 (06) : 1286 - 1293
  • [10] Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes
    de la Torre, JC
    Aliev, G
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (06) : 663 - 672